Stimulus-responsive viral vectors for controlled delivery of therapeutics

J Control Release. 2017 Dec 10:267:80-89. doi: 10.1016/j.jconrel.2017.08.021. Epub 2017 Aug 24.

Abstract

Virus-based therapies have gained momentum as the next generation of treatments for a variety of serious diseases. In order to make these therapies more controllable, stimulus-responsive viral vectors capable of sensing and responding to specific environmental inputs are currently being developed. A number of viruses naturally respond to endogenous stimuli, such as pH, redox, and proteases, which are present at different concentrations in diseases and at different organ and organelle sites. Additionally, rather than relying on natural viral properties, efforts are underway to engineer viruses to respond to endogenous stimuli in new ways as well as to exogenous stimuli, such as temperature, magnetic field, and optical light. Viruses with stimulus-responsive capabilities, either nature-evolved or human-engineered, will be reviewed to capture the current state of the field. Stimulus-responsive viral vector design considerations as well as gaps in current research efforts will be identified.

Keywords: Bioactivatable; Bioresponsive; Gene delivery; Gene therapy; Viral vector.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems*
  • Humans
  • Hydrogen-Ion Concentration
  • Oxidation-Reduction
  • Peptide Hydrolases
  • Physical Stimulation
  • Viruses*

Substances

  • Peptide Hydrolases